Form D · Other Health Care
Abacus Health Products, Inc.
Woonsocket, RI · CIK 0001753179
Offering snapshot reported Jan 8, 2019 · SEC filing
- Reported sold
- $2.57M Offering amount: $2.57M
- Investors reported
- 18 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 21, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 8, 2019 | Initial | $2,566,744 | No comparison | 18 | SEC filing |
| Sep 19, 2018 | Initial | $3,064,000 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-329893
Source: Form D, filed Jan 8, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Perry Antelman | Director, Executive |
| David Goldsmith | Director, Executive |
| Henry R. Hague | Executive |
| Philip C. Henderson | Director |
| Jesse Kaplan | Director |
| Eyal Rosenthal | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
184 Burnside Avenue
Woonsocket, RI, 02895
Woonsocket, RI, 02895